Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11020326
Hollow particles and cosmetic
granted -
US 11019810
Non-human animals having a humanized signal-regulatory protein gene
granted -
CA 3159588
VIRUS MVA RECOMBINANTS POUR L'ADMINISTRATION INTRATUMORALE ET/OU INTRAVEINEUSE POUR LE TRAITEMENT DU CANCER
granted -
WO 2021099616
MASITINIB POUR LE TRAITEMENT DE LA DRÉPANOCYTOSE
granted -
CA 3159666
UTILISATIONS MEDICALES DU VIRUS DE LA VACCINE ANKARA MODIFIE (MVA) RECOMBINANT 4-1 BBL
granted -
US 11013767
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11014955
Cyclic peroxides as prodrugs for selective delivery of agents
granted -
US 11015205
Oligomeric vaccines from plants by S-Tag-S-protein fusions
granted -
US 11014983
Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies
granted -
US 11013803
Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer
granted -
US 11013818
Library of pH responsive polymers and nanoprobes thereof
granted -
US 11013798
Orf virus-based platform for vaccine delivery
granted -
US 11013713
Method of treatment
granted -
US 11013805
Pharmaceutical compositions comprising meloxicam
granted -
US 11014895
Heterocyclic urea compound, and drug composition and application thereof
granted -
US 11015211
Cardiac cell reprogramming with myocardin and ASCL1
granted -
US 11015204
Synthesis and structure of high potency RNA therapeutics
granted -
US 11015200
Antisense-induced exon exclusion in myostatin
granted -
US 11014980
Transforming growth factor-beta-responsive polypeptides and their methods for use
granted -
US 11015023
Fire retardant compositions utilizing elemental sulfur
granted -
US 11014965
Modulation of complement activity
granted -
US 11014950
Nucleotide analogs
granted -
US 11014931
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator
granted -
US 11014921
Therapeutic compounds and methods of use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.